• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非酒精性脂肪性肝病中,炎症不是血清铁蛋白升高的原因。

Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease.

机构信息

Departments of Medicine Western University, London, Ontario, Canada.

Department of Pathology, Western University, London, Ontario, Canada.

出版信息

Ann Hepatol. 2014 May-Jun;13(3):353-6.

PMID:24756010
Abstract

BACKGROUND

In non-alcoholic fatty liver disease (NALFD), it has often been assumed that an elevation in serum ferritin is likely related to inflammation rather than iron overload.

MATERIAL AND METHODS

Patients referred with NAFLD were entered into a clinical study of phlebotomy therapy. A liver biopsy with liver iron concentration was done at entry and 6 months after phlebotomy (n = 56) until the patient had a low serum ferritin or developed anemia. Serum ferritin was compared to liver iron concentration, ESR, CRP, BMI and grade of inflammation on liver biopsy.

RESULTS

Iron removed by phlebotomy in NAFLD correlated with the decrease in serum ferritin (r = 0.57, p = 0.0014) and liver iron concentration (r = 0.57, p = 0.0013). There was no significant correlations between serum ferritin and ESR, CRP or grade of liver inflammation.

CONCLUSIONS

Serum ferritin is related to liver iron storage in NAFLD and decreasing body iron stores by phlebotomy is reflected by an appropriate decrease in serum ferritin. Inflammation is not the cause of the elevated serum ferritin in fatty liver disease.

摘要

背景

在非酒精性脂肪性肝病(NALFD)中,通常认为血清铁蛋白升高可能与炎症有关,而不是铁过载。

材料和方法

将患有 NALFD 的患者纳入放血疗法的临床研究中。在入组时和放血后 6 个月(n = 56)进行肝活检和肝铁浓度检查,直到患者的血清铁蛋白水平降低或出现贫血。将血清铁蛋白与肝铁浓度、ESR、CRP、BMI 和肝活检炎症程度进行比较。

结果

在 NALFD 中通过放血去除的铁与血清铁蛋白(r = 0.57,p = 0.0014)和肝铁浓度(r = 0.57,p = 0.0013)的降低相关。血清铁蛋白与 ESR、CRP 或肝炎症程度之间无显著相关性。

结论

血清铁蛋白与 NALFD 中的肝铁储存有关,通过放血去除体内铁储存会导致血清铁蛋白的适当降低。炎症不是脂肪性肝病中血清铁蛋白升高的原因。

相似文献

1
Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease.在非酒精性脂肪性肝病中,炎症不是血清铁蛋白升高的原因。
Ann Hepatol. 2014 May-Jun;13(3):353-6.
2
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.评估血清铁蛋白和肝铁与非酒精性脂肪性肝病严重程度的相关性。
Liver Int. 2019 Jul;39(7):1325-1334. doi: 10.1111/liv.14096. Epub 2019 Mar 27.
3
The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中血清血色素沉着症相关蛋白和铁调素水平与铁过载的关系
J Gastrointestin Liver Dis. 2015 Sep;24(3):293-300. doi: 10.15403/jgld.2014.1121.243.hak.
4
How should hyperferritinaemia be investigated and managed?高铁蛋白血症应如何进行检查和处理?
Eur J Intern Med. 2016 Sep;33:21-7. doi: 10.1016/j.ejim.2016.05.014. Epub 2016 Jun 23.
5
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.放血疗法导致的铁缺乏可改善非酒精性脂肪性肝病和高铁蛋白血症患者的胰岛素抵抗:一项病例对照研究的证据
Am J Gastroenterol. 2007 Jun;102(6):1251-8. doi: 10.1111/j.1572-0241.2007.01192.x. Epub 2007 Mar 27.
6
Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.在非酒精性脂肪性肝病中,铁调素水平与肝脏铁含量相关,但与脂肪性肝炎无关。
BMC Gastroenterol. 2018 Jun 5;18(1):78. doi: 10.1186/s12876-018-0804-0.
7
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up.血清铁蛋白升高与非酒精性脂肪性肝病 16 年随访后的死亡率升高相关。
Liver Int. 2016 Nov;36(11):1688-1695. doi: 10.1111/liv.13144. Epub 2016 Apr 28.
8
Iron stores assessment in alcoholic liver disease.酒精性肝病中铁储存评估
Scand J Gastroenterol. 2013 Jun;48(6):712-8. doi: 10.3109/00365521.2013.781217. Epub 2013 Mar 27.
9
Hepatic iron is the major determinant of serum ferritin in NAFLD patients.在非酒精性脂肪性肝病患者中,肝脏铁含量是血清铁蛋白的主要决定因素。
Liver Int. 2018 Jan;38(1):164-173. doi: 10.1111/liv.13513. Epub 2017 Jul 29.
10
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.铁蛋白水平与非酒精性脂肪性肝病严重程度相关性的诊断和治疗意义。
World J Gastroenterol. 2012 Aug 7;18(29):3782-6. doi: 10.3748/wjg.v18.i29.3782.

引用本文的文献

1
Association of serum iron status with MASLD and liver fibrosis.血清铁状态与代谢相关脂肪性肝病及肝纤维化的关联
PLoS One. 2025 Apr 1;20(4):e0319057. doi: 10.1371/journal.pone.0319057. eCollection 2025.
2
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.非酒精性脂肪性肝病中的铁代谢:一个有前景的治疗靶点。
Liver Res. 2022 Sep 19;6(4):203-213. doi: 10.1016/j.livres.2022.09.003. eCollection 2022 Dec.
3
Plasma Proteomic Markers of Iron and Risk of Diabetes in a Cohort of African American and White American Current and Former Smokers.
非裔美国人和美国白人当前及既往吸烟者队列中,铁的血浆蛋白质组学标志物与糖尿病风险的关系
Diabetes Metab Syndr Obes. 2024 Dec 11;17:4767-4776. doi: 10.2147/DMSO.S492124. eCollection 2024.
4
Do iron homeostasis biomarkers mediate the associations of liability to type 2 diabetes and glycemic traits in liver steatosis and cirrhosis: a two-step Mendelian randomization study.铁稳态生物标志物是否在 2 型糖尿病易感性与肝脂肪变性和肝硬化的血糖特征之间的关联中起中介作用:两步孟德尔随机化研究。
BMC Med. 2024 Jun 26;22(1):270. doi: 10.1186/s12916-024-03486-w.
5
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review.代谢功能障碍相关脂肪性肝炎与肝细胞癌的进展:文献综述
Cancers (Basel). 2024 Mar 20;16(6):1214. doi: 10.3390/cancers16061214.
6
Secondary Iron Overload and the Liver: A Comprehensive Review.继发性铁过载与肝脏:综述
J Clin Transl Hepatol. 2023 Aug 28;11(4):932-941. doi: 10.14218/JCTH.2022.00420. Epub 2023 Feb 1.
7
Iron and the Pathophysiology of Diabetes.铁与糖尿病的病理生理学。
Annu Rev Physiol. 2023 Feb 10;85:339-362. doi: 10.1146/annurev-physiol-022522-102832. Epub 2022 Sep 22.
8
Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.白人血色病和铁过载筛查研究中无 HFE p.C282Y/p.C282Y 参与者的铁过载表型和 HFE 基因型。
PLoS One. 2022 Jul 27;17(7):e0271973. doi: 10.1371/journal.pone.0271973. eCollection 2022.
9
Hyperferritinemia-A Clinical Overview.高铁蛋白血症——临床概述
J Clin Med. 2021 May 7;10(9):2008. doi: 10.3390/jcm10092008.
10
Efficacy of canagliflozin against nonalcoholic fatty liver disease: a prospective cohort study.卡格列净治疗非酒精性脂肪性肝病的疗效:一项前瞻性队列研究。
Obes Sci Pract. 2018 Aug 22;4(5):477-482. doi: 10.1002/osp4.294. eCollection 2018 Oct.